http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2014007020-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d32a49211015b18ecef5a3a5195bf06e |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7084 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7069 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4748 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 |
| filingDate | 2012-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2994b905012de132ac1fb1e70eeb29d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe05069eaada20b719f538f68ef9daa7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1229204194dce1238e61f431002158ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d963a25c616525b2919b95e40f48c370 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e44c1de19b8ce9b6a78c96b6a41064e2 |
| publicationDate | 2014-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | MX-2014007020-A |
| titleOfInvention | TRANSDERMAL ADMINISTRATION SYSTEM THAT INCLUDES BUPRENORFINA. |
| abstract | The invention relates to a transdermal therapeutic system for the transdermal administration of buprenorphine, which comprises a self-adhesive layer structure containing buprenorphine which comprises A) a buprenorphine impermeable backing layer, and B) a pressure sensitive adhesive layer containing buprenorphine on said buprenorphine impermeable backing layer, wherein the adhesive layer comprises a) at least one pressure sensitive polymer-based adhesive, b) an analgesically effective amount of buprenorphine base or a pharmaceutically acceptable salt thereof , and c) a carboxylic acid selected from the group consisting of oleic acid, linoleic acid, linolenic acid, levulinic acid and mixtures thereof, in an amount sufficient so that said analgesically effective amount of buprenorphine is solubilized therein, to form a mixture, and the mixture of carboxylic acid with buprenorphine forms dispersed deposits in said pressure sensitive adhesive, wherein said pressure sensitive adhesive layer containing buprenorphine is the layer that contacts the skin. |
| priorityDate | 2011-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 180.